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Associations of DASH Diet in Pregnancy 
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Hemodynamics, and Gestational 
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BACKGROUND: The Dietary Approaches to Stop Hypertension (DASH) diet improves blood pressure in nonpregnant popula-
tions. We hypothesized that adherence to the DASH diet during pregnancy improves hemodynamic adaptations, leading to a 
lower risk of gestational hypertensive disorders.
METHODS AND RESULTS: We examined whether the DASH diet score was associated with blood pressure, placental hemody-
namics, and gestational hypertensive disorders in a population-based cohort study among 3414 Dutch women. We assessed 
DASH score using food-frequency questionnaires. We measured blood pressure in early-, mid-, and late pregnancy (medians, 
95% range: 12.9 [9.8–17.9], 20.4 [16.6–23.2], 30.2 [28.6–32.6] weeks gestation, respectively), and placental hemodynamics in 
mid- and late pregnancy (medians, 95% range: 20.5 [18.7–23.1], 30.4 [28.5–32.8] weeks gestation, respectively). Information 
on gestational hypertensive disorders was obtained from medical records. Lower DASH score quartiles were associated with 
a higher mid pregnancy diastolic blood pressure, compared with the highest quartile (P<0.05). No associations were present 
for early- and late pregnancy diastolic blood pressure and systolic blood pressure throughout pregnancy. Compared with the 
highest DASH score quartile, the lower DASH score quartiles were associated with a higher mid- and late pregnancy umbili-
cal artery pulsatility index (P≤0.05) but not with uterine artery resistance index. No associations with gestational hypertensive 
disorders were present.
CONCLUSIONS: A higher DASH diet score is associated with lower mid pregnancy diastolic blood pressure and mid- and late 
pregnancy fetoplacental vascular function but not with uteroplacental vascular function or gestational hypertensive disorders 
within a low-risk population. Further studies need to assess whether the effects of the DASH diet on gestational hemodynamic 
adaptations are more pronounced among higher-risk populations.
Key Words: blood pressure ■ Dietary Approaches to Stop Hypertension ■ gestational hypertension ■ gestational hypertensive 
disorders ■ preeclampsia
Gestational hypertensive disorders affects up to 10% of pregnancies and are a major risk factor for maternal and neonatal morbidity and mortal-
ity.1 In nonpregnant populations, dietary interventions 
have been identified as an important strategy to re-
duce hypertension. The Dietary Approaches to Stop 
Hypertension (DASH) diet is a diet high in fruits, vege-
tables, total grains, nuts, seeds, legumes, and non-full-
fat dairy products and low in animal protein, sugar, and 
sodium.2 Multiple observation and intervention studies 
have shown that adherence to the DASH diet leads to 
lower blood pressure levels and improves lipid profile 
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and fasting glucose concentrations in nonpregnant 
adult populations.3–7
Not much is known about the influence of mater-
nal adherence to the DASH diet during pregnancy on 
gestational hemodynamic adaptations or the risk of 
gestational hypertensive disorders. Recently, a study 
among 511 pregnant women from Ireland showed that 
higher adherence to the DASH diet was associated 
with a lower diastolic blood pressure and mean arterial 
pressure in early- and late pregnancy.8 An intervention 
study in China among 85 pregnant women diagnosed 
with preexistent hypertension or gestational hyperten-
sion (ie, developed <28 weeks of gestation) showed a 
lower incidence of preeclampsia in the group adhering 
to the DASH diet.9 In contrast, 2 observational stud-
ies among 1760 American and 66 651 Danish women 
showed no associations of maternal adherence to the 
DASH diet with the risks of gestational hypertension or 
preeclampsia.10,11
We hypothesized that maternal adherence to the 
DASH diet may improve maternal hemodynamic ad-
aptations in pregnancy, leading to lower risks of ges-
tational hypertensive disorders.12–15 Therefore, we 
examined within a population-based cohort study 
among 3414 low-risk pregnant women, the associa-
tions of maternal DASH diet score with systolic and 
diastolic blood pressure and placental vascular func-
tion throughout pregnancy and the risks of gestational 
hypertensive disorders.
METHODS
The data that support the findings of this study are 
available from the corresponding author upon reason-
able request.
Study Design and Study Sample
The study was embedded in the Generation R study, 
a population-based prospective cohort from early 
pregnancy onwards in Rotterdam, The Netherlands.16 
Written informed consent was obtained of participat-
ing women. The study was approved by the Medical 
Ethical Committee of the Erasmus Medical Centre in 
Rotterdam, The Netherlands (MEC 198.782/2001/31). 
In total, 4096 women of Dutch ethnicity were enrolled 
during pregnancy. We excluded women with miss-
ing data on dietary intake (n=538), with missing data 
on all outcome measures (n=1), and with preexistent 
hypertension (n=63). Finally, we excluded loss to fol-
low-up (n=3), multiple gestations (n=53), and pregnan-
cies leading to fetal death (n=16) or induced abortions 
(n=8), leading to a cohort for analysis of 3414 pregnant 
women (Figure S1).
Maternal DASH Score
Semiquantitative self-administrated food frequency 
questionnaires (FFQ) of 293 food items were obtained 
at study enrollment at median 13.5 (95% range 10.2–
23.1) weeks gestation, and assessed dietary intake in 
the 3 months prior. Previously, the FFQ was validated in 
82 pregnant women with Dutch ethnic background.17,18 
As described previously, 136 of the 293 food items 
available from the FFQ were used to generate a DASH 
score.2 This score is composed of 8 food components, 
based mainly on the Fung method with a scoring sys-
tem based on quintile rankings.2,19 For intakes of total 
grains, vegetables, fruits, non-full-fat dairy products, 
and nuts/seeds/legumes, participating women re-
ceived a score from 1 (lowest quintile) to 5 (highest 
quintile). At the opposite, for intakes of red and pro-
cessed meats, sugar-sweetened beverages/sweets/
added sugars and sodium, participants were scored 
on a reverse scale. The food component scores were 
CLINICAL PERSPECTIVE
What Is New?
• In a low-risk population, maternal adherence to 
the Dietary Approaches to Stop Hypertension 
diet during pregnancy is associated with a lower 
mid pregnancy diastolic blood pressure and 
tends to be associated with improved fetopla-
cental vascular function.
• Maternal adherence to the Dietary Approaches 
to Stop Hypertension diet is not associated with 
uteroplacental vascular function or the risk of 
gestational hypertensive disorders in this low-
risk pregnant population.
What Are the Clinical Implications?
• Our findings suggest that the Dietary Approaches 
to Stop Hypertension diet might have small posi-
tive effects on gestational hemodynamic adapta-
tions in low-risk pregnant populations.
• These findings are important from an etiological 
perspective and on a population level.
• The beneficial effects may be more pronounced 
in pregnant populations with high a priori risk of 
developing gestational hypertensive disorders.
Nonstandard Abbreviations and Acronyms
DASH Dietary Approaches to Stop Hypertension
FFQ food frequency questionnaire
UmPI umbilical artery pulsatility index




 http://ahajournals.org by on February 10, 2021
J Am Heart Assoc. 2021;10:e017503. DOI: 10.1161/JAHA.120.017503 3
Wiertsema et al DASH Diet and Hemodynamic Adaptations in Pregnancy
summed to calculate an overall DASH score for each 
participant. A lower DASH score characterizes a lower 
dietary quality.2 In line with previous studies, we con-
structed quartiles of the maternal DASH score to as-
sess whether associations were restricted to a low 
DASH score only and constructed a maternal DASH 
SD score (SDS) to assess associations across the full 
range (range 10–37).10–12
Blood Pressure in Pregnancy
Systolic and diastolic blood pressure measurements 
were performed in early pregnancy (median 12.9 weeks 
of gestation, 95% range 9.8–17.9), mid pregnancy (me-
dian 20.4  weeks of gestation, 95% range 16.6–23.2), 
and late pregnancy (median 30.2  weeks of gesta-
tion, 95% range 28.6–32.6) using a validated Omron 
907 automated digital oscillometric sphygmomanom-
eter (OMRON Healthcare Europe BV, Hoofddorp, The 
Netherlands).20 Blood pressure measurements were 
performed with the participant in upright seated posi-
tion after a minimum waiting time of 5 minutes at rest. 
The cuff was placed around the upper arm at the level of 
the heart. The mean of 2 blood pressure measurements 
with a 60-second interval was used for further analysis.21
Placental Hemodynamic Parameters
Ultrasound examinations for placental hemodynamic 
parameters were carried out in 2 dedicated research 
centers during mid- (median 20.5  weeks of gesta-
tion, 95% range 18.7–23.1) and late pregnancy (me-
dian 30.4 weeks of gestation, 95% range 28.5–32.8). 
Umbilical artery pulsatility index (UmPI), uterine artery 
resistance index (UtRI), and bilateral third trimester 
uterine artery notching were assessed as primary 
placental hemodynamic parameters, as these meas-
ures are most commonly used in clinical practice and 
strongly associated with the risks of gestational hy-
pertensive disorders.22,23 As a secondary outcome, 
we also assessed uterine artery pulsatility index. The 
umbilical artery was assessed in a free-floating part of 
the umbilical cord.23 The uterine arteries were identi-
fied at the crossover with the external iliac artery. For 
each Doppler measurement 3 consecutive flow veloc-
ity wave forms were recorded. The mean of 3 Doppler 
measurements was used. Bilateral notching resulting 
from increased uterine artery resistance was defined 
as an increase of the waveform at the start of diastole 
in both uterine arteries.23,24
Gestational Hypertensive Disorders
Information on gestational hypertensive disorders was 
obtained from medical records. Women suspected 
of gestational hypertensive disorders based on these 
records were cross-checked with the original hospital 
charts, as described previously.25,26 Briefly, the follow-
ing criteria were used to identify women with gesta-
tional hypertension: development of systolic blood 
pressure of at least 140 mm Hg and/or diastolic blood 
pressure of at least 90 mm Hg after 20 weeks of gesta-
tion in women who were previously normotensive.25–27 
These criteria and the presence of proteinuria (defined 
as 2 or more dipstick readings of 2+ or greater, 1cath-
eter sample reading of 1+ or greater, or a 24-hour urine 
collection containing at least 300 mg of protein) were 
used to identify women with preeclampsia.25–27
Covariates
Data on maternal age, education level, parity, prepreg-
nancy weight, folic acid supplement use, alcohol use 
during pregnancy, smoking during pregnancy, and 
total energy intake were collected by questionnaires. 
Height was measured at enrollment and used to calcu-
late the prepregnancy body mass index (BMI).
Statistical Power
Power calculations within the Generation R study were 
performed based on 7000 subjects during the design 
of the study.28 For a normally distributed continuous 
outcome it is possible to detect a difference of 0.08 SD 
with a type I error of 5% and a type II error of 20% (power 
80%) if 25% of the cohort has the exposure, which cor-
responds to a mean difference of ≈0.90  mm  Hg for 
systolic blood pressure and 0.70 mm Hg for diastolic 
blood pressure. For gestational hypertensive disorders 
with a prevalence of ≈7%, an odds ratio of 1.26 to 1.38 
can be detected if 25% of the cohort has the relevant 
exposure.28
Statistical Analysis
First, we performed a nonresponse analysis compar-
ing characteristics of women with information on di-
etary intake (Figure S1) to women without information 
on dietary intake (Figure S2). Second, 1-way ANOVA 
and chi-square tests were used to compare popula-
tion characteristics across the maternal DASH score 
quartiles. Third, we analyzed the associations of ma-
ternal DASH score quartiles with longitudinal systolic 
and diastolic blood pressure patterns in absolute 
values using linear mixed models, which take the 
correlation between repeated measurements of the 
same subject into account and allow for incomplete 
outcome.29 We assumed a compound symmetry 
covariance structure and used restricted maximum 
likelihood estimation method. The DASH score quar-
tiles were included in the models as intercept and 
as an interaction term with gestational age to ex-
amine gestational age-independent (intercept) and 
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DASH score quartiles and gestational age). We used 
these models as descriptive analyses that present 
the absolute values for systolic and diastolic blood 
pressure across the DASH quartiles to reflect clini-
cal practice. Similar methods were used to examine 
the associations of maternal DASH score quartiles 
with longitudinal UmPI and UtRI patterns from sec-
ond trimester onwards. Furthermore, we examined 
the associations of maternal DASH score quartiles 
and SDS with differences in systolic and diastolic 
blood pressure in each pregnancy period using lin-
ear regression models to further enable assessment 
of small differences in blood pressure levels in each 
pregnancy period, which are relevant from an etio-
logical perspective and on a population level. Fourth, 
we examined the associations of maternal DASH 
score quartiles and SDS with differences in UmPI, 
UtRI, and uterine artery resistance index in mid- and 
late pregnancy using linear regression models and 
the risk of bilateral uterine artery notching using lo-
gistic regression models. Finally, we assessed the 
associations of maternal DASH score quartiles and 
SDS with the risk of gestational hypertensive disor-
ders using logistic regression analyses. As mater-
nal dietary intake is known to be strongly related to 
other sociodemographic and lifestyle characteristics, 
analyses were first only adjusted for gestational age 
at intake in the basic model and subsequently ad-
ditionally adjusted for maternal sociodemographic 
and lifestyle factors in the confounder model. To se-
lect potential confounders we used a directed acy-
clic graph and assessed whether covariates were 
associated with the exposure and outcome or led 
to a >10% change in effect estimate when added 
to the univariate model.30 Using these criteria, ma-
ternal age, educational level, parity, prepregnancy 
BMI, folic acid supplement use, smoking habits, al-
cohol use, total energy intake, and gestational age 
at time of the measurements were included in the 
confounder model for the main analyses focused on 
the continuous outcomes systolic and diastolic blood 
pressure, UmPI, and UtRI. As the number of cases for 
the adverse binary outcomes bilateral uterine artery 
notching, gestational hypertensive disorders, gesta-
tional hypertension, and preeclampsia was relatively 
low, we selected only those confounders that led to 
a >10% change in effect estimate when added to the 
univariate model for these specific outcomes. These 
confounder models included parity, prepregnancy 
BMI, folic acid supplement use, and gestational age 
at the time of intake. R2 values were obtained for the 
confounder models. To assess whether associations 
were different according to maternal prepregnancy 
BMI or parity, we tested statistical interaction terms 
but none were significant (P>0.05).24,26,31 We per-
formed multiple sensitivity analyses. We repeated 
the analyses excluding women with preexistent or 
gestational diabetes mellitus, hypercholesterolemia, 
or preexistent heart diseases, as these women rep-
resent higher-risk populations. We repeated the 
analyses restricting them to women who enrolled in 
early pregnancy (ie, <14 weeks of gestation) as ad-
herence to the DASH diet from preconception and 
early pregnancy onwards may have stronger effects 
on gestational hemodynamic adaptations. We re-
peated the analyses for binary outcomes with ad-
justment for a propensity score, to enable correction 
for a larger number of maternal sociodemographic 
and lifestyle-related characteristics, considering the 
relatively low number of cases of adverse outcomes. 
We constructed a propensity score using a logis-
tic regression model to estimate the probability of 
women having a dietary intake within DASH quartile 
1 as compared with DASH quartile 4. The propen-
sity score included maternal age, educational level, 
parity, prepregnancy BMI, folic acid supplement use, 
smoking habits, alcohol use, total energy intake, 
and gestational age at time of intake. The propen-
sity score was then included as a covariate in the re-
gression models.32,33 Missing data of covariates were 
imputed using multiple imputation. The percentage 
of missing values was <8% for all covariates, except 
for prepregnancy BMI (13.7%) and folic acid supple-
mentation (18%). Analysis were performed using IBM 
Statistical Package of Social Sciences version 25. 
The analysis for repeated measurements was per-
formed using Statistical Analysis System version 9.4.
RESULTS
Participant Characteristics
Population characteristics according to maternal DASH 
score quartiles are shown in Table 1. The mean DASH 
score was 24.6 (SD 4.6). Early pregnancy mean systolic 
and diastolic blood pressure did not differ significantly 
across the maternal DASH score quartiles. Mid preg-
nancy and late pregnancy mean systolic and diastolic 
blood pressure were highest in the lowest maternal 
DASH score quartile, decreased over the higher mater-
nal DASH score quartiles and were lowest in the highest 
maternal DASH score quartile (all P values for univari-
ate comparison across quartiles <0.05). Mid pregnancy 
and late pregnancy mean UtRI were highest in the low-
est maternal DASH score quartile, decreased over the 
higher maternal DASH score quartiles and were lowest 
in the highest maternal DASH score quartile (all P values 
for univariate comparison across quartiles <0.05). Mid- 
and late pregnancy mean UmPI did not differ significantly 
by maternal DASH score quartiles.
The composition of the DASH score and intake of 
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are shown in Table S1. Nonresponse analysis showed 
that no differences in blood pressure or gestational hy-
pertensive disorders were present among women with 
data on dietary intake compared with women without 
data on dietary intake (Table S2).
Maternal DASH Score and Blood Pressure 
Throughout Pregnancy
Figure shows the systolic and diastolic blood pres-
sure development during pregnancy in absolute val-
ues per maternal DASH score quartile. Women in 
the lowest DASH score quartile tended to have the 
highest overall systolic blood pressure and diastolic 
blood pressure throughout pregnancy, whereas 
women in the highest DASH score quartile tended to 
have the lowest overall systolic blood pressure and 
diastolic blood pressure throughout pregnancy. No 
consistent differences in the increase in blood pres-
sure per week were present for the different maternal 
DASH score quartiles (P values for interaction with 
gestational age >0.05). The regression coefficients 
for gestational age-independent (intercept) and ges-
tational age-dependent differences (interaction of 
DASH score quartile and gestational age) are given 
in Table S3.
Table 1. Characteristics of the Study Population by DASH Score Quartile (n=3414)*
Total Group
DASH Quartile 1 
Score 10–21
DASH Quartile 2 
Score 22–24
DASH Quartile 3 
Score 25–27
DASH Quartile 4 
Score 28–37
P Value‡n=3414 n=860 n=798 n=836 n=920
Maternal age at enrollment, mean (SD), y 31.4 (4.4) 29.7 (5.0) 31.2 (4.2) 32.0 (3.9) 32.5 (3.8) <0.001
Parity, n nulliparous (%) 2039 (59.9) 478 (55.7) 494 (62.1) 481 (57.6) 586 (63.8) 0.001
Prepregnancy BMI, mean (SD), kg/m2 23.1 (3.8) 23.8 (4.4) 23.3 (3.9) 23.1 (3.8) 22.4 (2.9) <0.001
Prepregnancy BMI ≥25 kg/m2, n (%) 655 (22.2) 217 (29.0) 151 (22.4) 159 (21.9) 128 (16.1) <0.001
Gestational weight gain, mean (SD), kg 10.8 (4.4) 10.8 (5.1) 10.8 (4.3) 10.8 (4.3) 10.8 (4.0) 1.00
Gestational age at intake, median  
(95% range), wk†
14.7 (10.2–23.1) 14.7 (9.6–23.7) 14.6 (9.9–23.4) 14.7 (9.9–24.0) 14.8 (10.5–22.5) 0.88
Higher education, n (%) 2000 (59.3) 285 (33.7) 456 (58.0) 560 (67.9) 699 (76.5) <0.001
Smoking, n continued (%) 538 (17.0) 259 (32.2) 128 (17.6) 74 (9.5) 77 (9.0) <0.001
Alcohol consumption, n continued (%) 1570 (50.0) 304 (38.3) 358 (49.4) 425 (54.9) 483 (56.9) <0.001
Folic acid supplement use, n (%) 2493 (89.1) 551 (80.8) 575 (88.9) 646 (92.7) 721 (93.3) <0.001
Total energy intake, mean (SD), kcal/d 2146.9 (511.5) 2078.1 (548.1) 2135.2 (535.6) 2162.8 (491.9) 2206.8 (462.3) <0.001
Systolic blood pressure, mean (SD), mm Hg
Early pregnancy 117.3 (11.9) 117.8 (11.9) 117.4 (12.6) 117.3 (12.3) 116.6 (11.0) 0.29
Mid pregnancy 118.5 (11.7) 119.5 (12.0) 118.9 (12.2) 118.0 (11.7) 117.5 (10.9) 0.002
Late pregnancy 120.4 (11.4) 121.3 (12.2) 121.1 (11.8) 119.7 (10.9) 119.5 (10.8) 0.001
Diastolic blood pressure, mean (SD), mm Hg
Early pregnancy 68.5 (9.2) 68.9 (9.2) 68.6 (10.1) 68.4 (9.0) 68.1 (8.5) 0.47
Mid pregnancy 67.2 (9.3) 68.3 (9.7) 67.7 (9.7) 66.9 (8.9) 66.1 (8.5) <0.001
Late pregnancy 69.4 (9.2) 70.0 (9.6) 69.6 (9.3) 69.0 (8.7) 68.8 (9.0) 0.05
Umbilical artery pulsatility index, mean (SD)
Mid pregnancy 1.19 (0.18) 1.20 (0.18) 1.20 (0.18) 1.18 (0.17) 1.17 (0.18) 0.01
Late pregnancy 0.98 (0.17) 1.00 (0.18) 0.97 (0.16) 0.98 (0.16) 0.96 (0.16) <0.001
Uterine artery resistance index, mean (SD)
Mid pregnancy 0.535 (0.089) 0.535 (0.091) 0.535 (0.090) 0.535 (0.089) 0.535 (0.088) 1.00
Late pregnancy 0.483 (0.078) 0.490 (0.076) 0.484 (0.076) 0.480 (0.081) 0.479 (0.08) 0.11
Third trimester bilateral uterine artery 
notching, n (%)
48 (2.2) 13 (2.5) 11 (2.2) 10 (1.8) 14 (2.3) 0.91
Gestational hypertensive disorders, n (%)
Gestational hypertension 173 (5.3) 51 (6.3) 42 (5.4) 34 (4.2) 46 (5.2) 0.34
Preeclampsia 59 (1.9) 19 (2.4) 7 (1.0) 20 (2.5) 13 (1.5) 0.07
BMI indicates body mass index; DASH, Dietary Approaches to Stop Hypertension.
*Values are means (SD) or percentages.
†Median (95% range).
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The associations of maternal DASH score quar-
tiles and SDS with differences in systolic and diastolic 
blood pressure in early-, mid-, and late pregnancy are 
given in Table  2. After adjustment for maternal so-
ciodemographic and lifestyle factors, lower maternal 
DASH score quartiles, as compared with the highest 
maternal DASH score quartile, were associated with 
a higher mid pregnancy diastolic blood pressure only 
(P<0.05, R2=0.16). A higher maternal DASH score 
across the full range was also significantly associated 
with a lower mid pregnancy diastolic blood pressure 
in the confounder model (difference −0.45 [95% CI, 
−0.78–−0.12] mm  Hg per SDS increase in maternal 
DASH score, R2=0.16) but not with diastolic blood 
pressure in early- or late pregnancy or systolic blood 
pressure throughout pregnancy. In the basic models, 
lower maternal DASH score quartiles were associated 
with a higher systolic and diastolic blood pressure in 
mid- and late pregnancy as compared with the highest 
maternal DASH score quartile (all P<0.05) (Table S4).
Maternal DASH Score and Placental 
Vascular Function
Table S5 shows that in the basic models, compared 
with the highest maternal DASH score quartile, the 
lower maternal DASH score quartiles were associ-
ated with a higher UmPI in mid- and late pregnancy 
Table 2. Associations of Maternal DASH Score With Systolic and Diastolic Blood Pressure in Early-, Mid-, and Late 
Pregnancy (n=3414)*
DASH Score







Quartile 1 Absolute mean value (SD)† 
Confounder model‡
117.8 (11.9) 
−0.39 (−1.62 to 0.84) 
n=702
119.5 (12.0) 
0.05 (−1.09 to 1.18) 
n=823
121.3 (12.2) 
−0.16 (−1.27 to 0.96) 
n=825
Quartile 2 Absolute mean value (SD)† 
Confounder model‡
117.4 (12.6) 
−0.35 (−1.53 to 0.82) 
n=664
118.9 (12.2) 
0.08 (−0.99 to 1.15) 
n=773
121.1 (11.8) 
0.45 (−0.60 to 1.49) 
n=782
Quartile 3 Absolute mean value (SD)† 
Confounder model‡
117.3 (12.3) 
−0.02 (−1.11 to 1.17) 
n=704
118.0 (11.7) 
−0.13 (−1.18 to 0.91) 
n=808
119.7 (10.9) 
−0.35 (−1.37 to 0.68) 
n=815











Trend§ 0.19 (−0.26 to 0.64) −0.01 (−0.43 to 0.40) 0.07 (−0.33 to 0.48)
DASH Score







Quartile 1 Absolute mean value (SD)† 
Confounder model‡
68.9 (9.2) 
0.18 (−0.77 to 1.13) 
n=702
68.3 (9.7) 
1.31* (0.42 to 2.21) 
n=822
70.0 (9.6) 
0.09 (−0.79 to 0.97) 
n=825
Quartile 2 Absolute mean value (SD)† 
Confounder model‡
68.6 (10.1) 
−0.18 (−1.09 to 0.72) 
n=664
67.7 (9.7) 
0.85* (0.01 to 1.69) 
n=773
69.6 (9.3) 
−0.01 (−0.84 to 0.81) 
n=781
Quartile 3 Absolute mean value (SD)† 
Confounder model‡
68.4 (9.0) 
−0.19 (−1.07 to 0.69) 
n=704
66.9 (8.9) 
0.33 (−0.49 to 1.15) 
n=808
69.0 (8.7) 
−0.21 (−1.02 to 0.60) 
n=815











Trend§ −0.05 (−0.39 to 0.30) −0.45* (−0.78 to −0.12) −0.06 (−0.38 to 0.26)
DASH indicates Dietary Approaches to Stop Hypertension; DBP, diastolic blood pressure; and SBP, systolic blood pressure.
*P<0.05.
†Values are unadjusted mean blood pressure values (SD) and reflect the absolute value in SBP and DBP per DASH quartile.
‡Values are regression coefficients (95% CI) and reflect the difference in mm Hg blood pressure per maternal DASH score quartile. Groups are compared with 
women with the highest dietary quality according to the DASH score (quartile 4) as reference. Estimates are from multiple imputed data. Models are adjusted for 
maternal age, educational level, parity, prepregnancy body mass index, smoking habits, alcohol use, folic acid use, total energy intake, and gestational age at 
time of the measurements. R2 values: early pregnancy SBP, R2=0.15; mid pregnancy SBP, R2=0.15, late pregnancy SBP, R2=0.13; early pregnancy DBP, R2=0.14; 
mid pregnancy DBP, R2=0.16; late pregnancy, R2=0.16.
§Trends were based on multiple linear regression models with DASH as SD scores. R2 values: early pregnancy SBP, R2=0.15; mid pregnancy SBP, R2=0.14, 
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(P<0.05, P values for trend <0.05), but not with UtRI 
or bilateral notching. We observed similar results when 
we used repeated measurement models to examine 
longitudinal placental vascular development from mid 
pregnancy onwards (Table  S6). Table  3 shows that 
as compared with the highest maternal DASH score 
quartile, the lowest maternal DASH score quartile was 
associated with a higher late pregnancy UmPI (P<0.05, 
R2=0.04) after adjustment for maternal sociodemo-
graphic and lifestyle factors. A higher maternal DASH 
score across the full range was also associated with a 
lower late pregnancy UmPI (difference −0.008 [95% CI, 
−0.015–−0.002] per SDS increase in maternal DASH 
score, R2=0.04). Similar tendencies were present for 
maternal DASH score quartiles and across the full 
range with mid pregnancy UmPI, but these associa-
tions were not significant. No consistent associations 
of maternal DASH score quartiles and SDS with mid- 
or late pregnancy UtRI or bilateral notching were pre-
sent after adjustment for maternal sociodemographic 
and lifestyle factors. Similarly, Table  S7 shows that 
mid- and late pregnancy mean uterine artery pulsatility 
index did not differ significantly across maternal DASH 
score quartiles. No associations of maternal DASH 
score quartiles or SDS with uterine artery pulsatility 
index were observed after adjustment for sociodemo-
graphic and lifestyle factors.
Maternal DASH Score and Risks 
of Gestational Hypertension and 
Preeclampsia
Table 4 shows that maternal DASH score in quartiles 
and SDS were not significantly associated with the 
risks of any gestational hypertensive disorder, gesta-
tional hypertension, or preeclampsia in the adjusted 
models. Comparable findings were present in the 
basic models (Table S8).
Sensitivity Analyses
Similar results were present when we excluded 
women with preexistent and gestational diabetes mel-
litus (Tables S9 through S11) and when we excluded 
women with hypercholesterolemia and/or a heart con-
dition (Tables  S12 through S14). When we restricted 
the analysis to women who enrolled before 14 weeks of 
gestation, similar findings were present for systolic and 
diastolic blood pressure and gestational hypertensive 
disorders, but no associations of maternal DASH score 
quartiles or SDS with placental hemodynamic parame-
ters were observed (Tables S15 through S17). When we 
used propensity scores to adjust for potential maternal 
sociodemographic and lifestyle-related confounding 
factors, we observed similar results for bilateral uterine 
artery notching and gestational hypertensive disorders 
as compared with conventional covariate adjustment 
in the multivariable regression models (Table S18).
DISCUSSION
Within this low-risk population-based cohort study, we 
observed that a higher maternal DASH diet score was 
associated with a lower mid pregnancy diastolic blood 
pressure but not with diastolic blood pressure in early- 
or late pregnancy or systolic blood pressure through-
out pregnancy. A higher maternal DASH diet score 
tended to be associated with a lower mid- and late 
pregnancy UmPI but not with other placental hemody-
namic parameters. No associations were present with 
the risks of gestational hypertensive disorders.
Interpretation of Main Findings
The DASH diet is a diet high in fruits, vegetables, total 
grains, nuts, seeds, legumes, and non-full-fat dairy 
products, and low in animal protein, sugar, and so-
dium.2 This dietary approach has gained substantial 
attention for its blood pressure lowering properties in 
nonpregnant populations. In the original clinical trial 
among 459 participants with systolic blood pressure 
of <160 mm Hg and diastolic blood pressure of 80 to 
95 mm Hg, the DASH diet led to a significant reduc-
tion of systolic and diastolic blood pressure by 5.5 and 
3.0 mm Hg, with even stronger effects in hypertensive 
individuals.3 These results have been reproduced in 
numerous other intervention and observational studies 
that suggest beneficial effects on cardiovascular risk 
factors and long-term cardiovascular outcomes.4–7,12 
The DASH diet is accordingly recommended by the 
American Heart Association to manage blood pres-
sure, improve lipid profile, and reduce the risks of heart 
attack and stroke.34 We hypothesized that maternal 
adherence to the DASH diet during pregnancy may 
also reduce the risks of gestational hypertensive dis-
orders through its potential positive effects on blood 
pressure and vascular function.
Not much is known about the influence of mater-
nal adherence to the DASH diet during pregnancy 
on blood pressure development or placental vascu-
lar function in pregnancy. The DASH diet has some 
resemblance in dietary properties when compared 
with the Mediterranean diet. Maternal adherence to 
a Mediterranean dietary pattern has been associated 
with lower blood pressure in early- and mid pregnancy 
and lower placental vascular hemodynamic parame-
ters in low-risk and higher-risk populations.35–38 In line 
with these findings, an observational study in Ireland 
among 511 women with a large-for-gestational-age in-
fant in their previous pregnancy, showed that higher 
maternal adherence to the DASH diet in their second 
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pressure and mean arterial pressure in early- and late 
pregnancy, but not in mid pregnancy.8 Within this 
study dietary intake was recorded in each trimester of 
pregnancy using a 3-day food diary, but no extensive 
adjustment for other lifestyle factors was performed.8 
A small intervention study among 34 Irani women 
with gestational diabetes mellitus also described a 
favorable influence on third trimester systolic blood 
pressure after adhering to the DASH diet for 4 weeks 
compared with a control diet.35–39 Contrary, an obser-
vational study among 1760 pregnant women in the 
United States showed no associations of DASH diet 
score with third trimester blood pressure in a low-risk 
multiethnic population.10
Only partly in line with the previous studies focused 
on adherence to a Mediterranean diet and the DASH 
diet, we did not find consistent associations of a higher 
maternal DASH diet score with systolic and diastolic 
blood pressure development throughout pregnancy 
after adjustment for sociodemographic and lifestyle 
factors in a low-risk population. A higher maternal 
DASH diet score was associated with a only small 
Table 4. Associations of Maternal DASH Score With the Risks of Gestational Hypertensive Disorders (n=3414)
DASH Score
Gestational Hypertensive Disorders* Gestational Hypertension* Preeclampsia*
Odds Ratio (95% CI) 
ncases=232
Odds Ratio (95% CI) 
ncases=173
Odds Ratio (95% CI) 
ncases=59
























Trend† 0.95 (0.83–1.10) 0.96 (0.81–1.12) 0.94 (0.72–1.23)
DASH indicates Dietary Approaches to Stop Hypertension; GH, gestational hypertension; GHD, gestational hypertensive disorders; and PE, preeclampsia.
*Values are odds ratios (95% CI) that reflect difference in risks of gestational hypertensive disorders, gestational hypertension, and preeclampsia per DASH 
quartile. Groups are compared with women with the highest dietary quality according to the DASH score (quartile 4) as reference. Estimates are from multiple 
imputed data. Models are adjusted for parity, prepregnancy body mass index, folic acid use, and gestational age at time of intake. R2 values: GHD, R2=0.09; 
GH, R2=0.10; PE, R2=0.08.
†Trends were based on multiple logistic regression models with DASH as SD scores. R2 values: GHD, R2=0.09; GH, R2=0.10; PE, R2=0.08.
Figure. Blood pressure patterns in different DASH categories.
Change in systolic blood pressure (SBP) and diastolic blood pressure (DBP) in mm  Hg for first quartile, second quartile, third 
quartile, and fourth quartile. SBP=ß0+ß1×DASH quartile+ß2×gestational age+ß3×gestational age
−2+ß4×DASH quartile×gestational 
age. DBP=ß0+ß1×DASH quartile+ß2×gestational age+ß3×gestational age
0,5+ß4×DASH quartile×gestational age. In these models, 
“ß0+ß1×DASH” reflects the intercept and “ß2×gestational age+ß3×gestational age
−2”reflects the slope of change in blood pressure per 
week for SBP, and “ß2×gestational age+ß3×gestational age
0,5”, reflects the slope of change in blood pressure per week for DBP. Our 
term of interest is ß4, which reflects the difference in change in blood pressure per week per DASH category, as compared with women 
















































 http://ahajournals.org by on February 10, 2021
J Am Heart Assoc. 2021;10:e017503. DOI: 10.1161/JAHA.120.017503 10
Wiertsema et al DASH Diet and Hemodynamic Adaptations in Pregnancy
reduction in mid pregnancy diastolic blood pressure. A 
higher maternal DASH diet score also tended to be as-
sociated with lower umbilical artery vascular resistance 
in mid- and late pregnancy but not with uteroplacental 
vascular function. The UmPI reflects the development 
of the fetoplacental vascular tree. Already small in-
creases in mid- and late pregnancy fetoplacental vas-
cular resistance are associated with increased risks of 
gestational hypertension and preeclampsia.22,23 These 
observed associations with mid pregnancy diastolic 
blood pressure and fetoplacental vascular function 
may be explained by improved endothelial cell function 
and reduction of oxidative stress through the DASH 
diet and potential positive effects on the renin-angio-
tensin-aldosterone system via sodium reduction.12,13,15 
Through these mechanisms, the DASH diet may pos-
itively affect physiological hemodynamic adaptations 
in pregnancy, which could explain the strongest effect 
on mid pregnancy diastolic blood pressure, when the 
physiological diastolic blood pressure dip in pregnancy 
occurs.10,40 The beneficial effects on endothelial func-
tion may be more apparent on the fetoplacental vascu-
lar function than the uteroplacental vascular function, 
as the vasomotor tone of the fetoplacental vasculature 
is fully regulated by endothelial derived vasoactive 
mediators, whereas the uteroplacental vascular bed 
is also influenced by autonomic regulation.41–43 Thus, 
this suggest that these potential beneficial effects of 
the DASH diet on gestational hemodynamic adap-
tations may be more pronounced among higher-risk 
populations.8,39
Three studies explored the effects of the DASH 
diet on the risks of gestational hypertensive disor-
ders. A prospective cohort among 1760 pregnant 
women in the United States did not observe any 
associations of first trimester DASH diet score with 
gestational hypertension or preeclampsia.10 A cohort 
among 66 651 women with singleton pregnancies in 
Denmark showed no association of maternal DASH 
diet score at 25 weeks gestation with the risk of ges-
tational hypertensive disorders.11 In line with these 
previous studies, we observed no significant asso-
ciations of maternal DASH diet score with the risk 
of gestational hypertensive disorders. We observed 
a tendency for an association of a higher maternal 
DASH diet score with a lower risk of preeclampsia, 
but this association was not significant. This might 
indicate a type II error because of a relatively small 
number of preeclampsia cases within our low-risk 
population. Contrary to our findings, a beneficial 
effect of the DASH diet was found in a randomized 
controlled trial in China among 85 high-risk pregnant 
women diagnosed with preexistent hypertension 
or gestational hypertension. They found a lower in-
cidence of preeclampsia when women adhered to 
the DASH diet compared with a control diet during a 
12-week intervention period.9 Thus, our findings sug-
gest that in a low-risk pregnant population, higher 
maternal DASH diet score is not associated with a 
lower risk of gestational hypertensive disorders. 
Stimulating maternal adherence to the DASH diet 
might be more clinically relevant in pregnant popula-
tions with a high a priori risk of gestational hyperten-
sive disorders.
Within our low-risk Dutch population, we did not 
observe consistent and strong positive associations 
of higher maternal DASH diet score with systolic 
and diastolic blood pressure development through-
out pregnancy, uteroplacental vascular function, or 
the risks of gestational hypertensive disorders after 
considering maternal sociodemographic and lifestyle 
factors. There remained only a relatively small as-
sociation of higher maternal DASH diet score with a 
lower mid pregnancy diastolic blood pressure and a 
tendency to lower fetoplacental vascular resistance 
from mid pregnancy onwards, after adjustment for 
maternal sociodemographic and lifestyle factors. 
These observed associations were small and within 
the normal range of maternal blood pressure and 
umbilical artery vascular resistance. However, we do 
consider these findings important from an etiologi-
cal perspective and on a population level. Overall, we 
observed that participating women already adhered 
to components of the DASH diet and subsequently 
the range of DASH diet score within our study popu-
lation was moderate. Possibly, among pregnant pop-
ulations with a larger variability in dietary intake, the 
influence of higher maternal adherence to the DASH 
diet on gestational hemodynamic adaptations is more 
apparent. Within our study population, blood pres-
sure was also mainly within the normotensive range. 
We excluded women with preexistent hypertension. 
Among pregnant women with an already increased 
baseline blood pressure, the beneficial effects of the 
DASH diet on gestational hemodynamic adaptations 
could be more apparent as was demonstrated in 
earlier research in nonpregnant populations.3 Further 
studies are needed to explore the effects of ad-
herence to the DASH diet in higher-risk multiethnic 
pregnant populations on gestational hemodynamic 
adaptations and the risks of gestational hyperten-
sive disorders to assess whether recommending the 
DASH diet for these higher-risk pregnant women may 
improve their pregnancy outcomes.
Strengths and Limitations
We had a prospective data collection from early 
pregnancy onwards and a large sample size. The 
response rate for participation in the Generation R 
cohort was 61% at baseline, which reflects the num-
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a percentage of the total number of pregnant women 
who fulfilled the eligibility criteria in the study area.16 
We restricted to women of Dutch ethnicity, which 
may have affected the generalizability of our findings. 
Information on gestational hypertensive disorders 
was obtained from medical records, using definitions 
of gestational hypertensive disorders used in clinical 
practice at the time.27 The definition of preeclampsia 
has been updated,44 which might affect the gener-
alizability of our findings to current clinical practice. 
Within our study population, we had a relatively small 
number of gestational hypertensive disorders and 
bilateral uterine artery notching cases, which might 
indicate a selection toward a relatively healthy low-
risk population. Additionally, it may have led to lack 
of statistical power for these specific analyses and 
the possibility of a type II error. Further studies within 
larger populations with more cases of placental in-
sufficiency and gestational hypertensive disorders 
are needed using the most up-to-date classification 
for gestational hypertensive disorders to examine 
these associations in further detail with increased 
statistical power. Women with preexistent hyperten-
sion or other cardiovascular diseases may be at in-
creased risk of impaired gestational hemodynamic 
adaptations and developing gestational hypertensive 
disorders.45 Importantly, women with preexistent hy-
pertension were excluded from our study population 
and we observed similar findings when we addition-
ally excluded women with hypercholesterolemia and 
a heart condition from the analyses. Given the rela-
tively young age of participating women, we consider 
it unlikely that a high percentage of women already 
had other preexistent cardiovascular diseases, but 
we did not have more detailed information available. 
Further studies with detailed assessments of mater-
nal cardiovascular health before and during preg-
nancy are needed to assess whether adherence to 
the DASH diet has a different effect on gestational 
hemodynamic adaptations in low-risk and higher-risk 
populations. Although the FFQs were validated previ-
ously and are a commonly used method to assess 
dietary intake, reporting bias may be an issue as the 
FFQ was self-administered and components of the 
DASH diet are food items that are generally known for 
their healthy or less healthy properties. We assessed 
maternal dietary intake by FFQ at enrollment in the 
study. Owing to the design of our study, the timing 
of the FFQ administration is relatively broad.28 As the 
FFQ reflects maternal dietary intake in the 3 months 
prior, this approach allowed us to assess maternal 
dietary intake just before pregnancy and in the first 
half of pregnancy and reduces the risk of recall bias. 
Importantly, some women may have changed their 
diet already at an earlier stage in the preconception 
period in order to improve their own health and fertil-
ity or may have changed their diet when they became 
pregnant. Further studies from preconception on-
wards are needed with detailed dietary assessments 
in the preconception period and during pregnancy to 
identify critical periods for maternal dietary intake on 
gestational hemodynamic adaptations and the risk of 
gestational hypertensive disorders. Information on a 
large number of covariates was available within our 
study to adjust for potential confounding within our 
main analyses. We could adjust for only a relatively 
small set of confounders for bilateral uterine artery 
notching and gestational hypertensive disorders be-
cause of the relatively low number of cases. However, 
we observed similar results when we used a propen-
sity score to adjust for a larger number of maternal 
sociodemographic and lifestyle-related character-
istics. As in any observational study residual con-
founding might still be an issue.
CONCLUSIONS
In a low-risk pregnant population, higher maternal ad-
herence to DASH diet was associated with a lower mid 
pregnancy diastolic blood pressure and tended to be 
associated with a lower mid- and late pregnancy um-
bilical artery vascular resistance but not with systolic 
blood pressure, uteroplacental vascular resistance, or 
the risk of gestational hypertensive disorders. Further 
studies are needed to assess whether maternal ad-
herence to the DASH diet has more pronounced posi-
tive effects on gestational hemodynamic adaptations 
and the risks of gestational hypertensive disorders in 
higher-risk populations.
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Table S1. Dietary intake of DASH food components by DASH score quartile (n=3,414)*. 
DASH, Dietary Approaches to Stop Hypertension. g/d, daily amount in grams and/or milliliters per day. mg/d, daily amount in milligrams per day.  
*Values are median (inter quartile range). †Values are mean (sd).
 Total group DASH quartile 1 
score 10-21 
DASH quartile 2 
score 22-24 
DASH quartile 3 
score 25-27 
DASH quartile 4 
score 28-37 
 
 n=3,414 n=860 n=798 n=836 n=920 p-value 
Total grains, g/d 174 (122 – 218) 128 (88 – 177) 168 (117 – 208) 183 (139 – 222) 203 (162 – 246) <0.001 
Vegetables (excluding potatoes 
and condiments), g/d 
143 (105 – 186) 104 (76 – 136) 129 (101 – 160) 151 (121 – 190) 188 (151 – 231) <0.001 
Fruits, g/d 296 (192 – 441) 202 (121 – 299) 275 (187 – 414) 319 (214 – 454) 389 (281 – 525) <0.001 
Non-full-fat dairy products, g/d 310 (171 – 462) 191 (94 – 386) 273 (154 – 445) 326 (204 – 473) 409 (266 – 549) <0.001 
Nuts, seeds, legumes, g/d  13 (6 – 23) 7 (2 – 13) 11 (5 – 18) 14 (7 – 24) 22 (13 – 35) <0.001 
Red and processed meats, g/d 53 (35 – 75) 74 (54 – 93) 60 (44 – 78) 49 (34 – 65) 36 (21 – 52) <0.001 
Sugar-sweetened beverages, 
sweets and added sugars, g/d 
65 (33 – 140) 156 (83 – 262) 76 (38 – 148) 57 (31 – 99) 39 (21 – 63) <0.001 
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Table S2. Non-response analysis: characteristics of participating women with and without data 
on dietary intake * 
*Values are means (sd) or percentages. †Women with data on dietary intake as described in Figure S1‡ 
Women without data on dietary intake as described in Figure S2 §Median (95% range). §Median (95% 
range). 
 
 Participants with 
data on dietary 
intake† 
Participants 
without data on 
dietary intake ‡ 
 
 n=3,414 n=512 p-value 
Maternal age at enrolment, mean 
(sd), years 
31.4 (4.4) 30.3 (5.3) <0.001 
Parity, n nulliparous (%) 2039 (59.9) 291 (57.3) 0.27 
Prepregnancy BMI, mean (sd) 23.1 (3.8) 23.1 (4.1) 0.80 
 Prepregnancy BMI ≥25 655 (22.2) 98 (23.1) 0.68 
Gestational weight gain, mean (sd), 
kg 
10.8 (4.4) 11.3 (4.8) 0.05 
Gestational age at intake (weeks)§ 14.7 (10.2, 23.1) 14.1 (10.3, 30.4) <0.001 
Higher education, n (%) 2000 (59.3) 232 (46.6) <0.001 
Smoking, n continued (%) 538 (17.0) 116 (25.3) <0.001 
Alcohol consumption, n continued 
(%) 
1570 (50.0) 202 (44.4) 0.025 
Folic acid supplement use, n (%) 2493 (89.1) 332 (82.0) <0.001 
Systolic blood pressure, mean (sd), 
mmHg 
   
Early-pregnancy 117.3 (11.9) 117.6 (12.3) 0.60 
Mid-pregnancy 118.5 (11.7) 118.5 (10.9) 0.92 
Late-pregnancy 120.4 (11.4) 119.7 (11.4) 0.20 
Diastolic blood pressure, mean (sd), 
mmHg 
   
Early-pregnancy 68.5 (9.2) 68.1 (9.5) 0.48 
Mid-pregnancy 67.2 (9.3) 67.0 (9.5) 0.61 
Late-pregnancy 69.4 (9.2) 69.5 (9.3) 0.76 
Umbilical artery pulsatility index, 
mean (sd) 
   
Mid-pregnancy 1.19 (0.18) 1.22 (0.18) 0.008 
Late-pregnancy 0.98 (0.17) 0.98 (0.18) 0.37 
Uterine artery resistance index, 
mean (sd) 
   
Mid-pregnancy 0.535 (0.089) 0.545 (0.090) 0.08 
Late-pregnancy 0.483 (0.078) 0.481 (0.077) 0.62 
Late-pregnancy notching, n (%) 48 (2.2) 2 (0.6) 0.07 
Gestational hypertensive disorders, 
n (%) 
   
 Gestational hypertension 173 (5.3)  24 (4.9) 0.74 
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Table S3. Longitudinal associations between DASH score and systolic and diastolic blood 
pressure*  
DASH, Dietary Approaches to Stop Hypertension.  
*Values are based on repeated non-linear regression models and reflect the change in blood pressure in 
mmHg per DASH quartile compared to women with the highest dietary quality (quartile 4) as 
reference. Models are adjusted for gestational age at the time of measurements. †P-value reflects the 
significance level of the estimate. 
 
 Difference in systolic blood pressure (mmHg) 
DASH Intercept P-value
† Slope (mmHg(95%CI)) P-value† 
Quartile 1 113.5 0.08 0.01 (-0.06, 0.08) 0.75 
Quartile 2 112.5 0.56 0.04 (-0.03, 0.10) 0.31 
Quartile 3 113.4 0.10 -0.05 (-0.11, 0.02) 0.18 
Quartile 4 111.9 Reference Reference  Reference 
 Difference in diastolic blood pressure (mmHg) 
DASH Intercept
 P-value† Slope (mmHg(95%CI)) P-value† 
Quartile 1 100.1 0.08 0.01 (-0.04, 0.06) 0.70 
Quartile 2 99.6 0.32 0.01 (-0.03, 0.06) 0.64 
Quartile 3 99.7 0.25 -0.02 (-0.07, 0.04) 0.54 
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Table S4. Basic models: associations of maternal DASH score with systolic and diastolic blood 
pressure in early-, mid- and late-pregnancy (n=3,414). 
DASH, Dietary Approaches to Stop Hypertension.  
* P-value <0.05.†Values are regression coefficients (95% confidence interval) and reflect the 
difference in mmHg blood pressure per DASH quartile. Groups are compared to women with the 
highest dietary quality (quartile 4) as reference. Models are adjusted for gestational age at the time of 
intake. Estimates are from multiple imputed data. ‡Trends were based on multiple linear regression 
models with DASH as SDS. Models are adjusted for gestational age at the time of intake. Estimates 
are from multiple imputed data.








Quartile 1† 1.14 (-0.09, 2.36) 
n=702 
1.97 (0.87, 3.08)* 
n=823 
1.77 (0.69, 2.85)* 
n=825 
Quartile 2† 0.70 (-0.54, 1.94) 
n=664 
1.28 (0.16, 2.41)* 
n=773 
1.54 (0.45, 2.64)* 
n=782 
Quartile 3† 0.62 (-0.60, 1.84) 
n=704 
0.49 (-0.62, 1.60) 
n=808 
0.17 (-0.91, 1.25) 
n=815 






Trend‡ -0.40 (-0.83, -0.04) -0.77 (1.16, -0.37)* -0.69 (-1.08, -0.30)* 








Quartile 1† 0.69 (-0.25, 1.64) 
n=702 
2.19 (1.32, 3.06)* 
n=822 
1.11 (0.24, 1.97)* 
n=825 
Quartile 2† 0.38 (-0.58, 1.33) 
n=664 
1.57 (0.68, 2.45)* 
n=773 
0.75 (-0.13, 1.63) 
n=781 
Quartile 3† 0.23 (-0.71, 1.17) 
n=704 
0.76 (-0.12, 1.64) 
n=808 
0.20 (-0.67, 1.07) 
n=815 
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Table S5. Basic models: associations of DASH score with placental vascular function (n=3,414). 
 
 Umbilical artery pulsatility index











Quartile 1 0.027 (0.007, 0.047)* 
n=598 
0.038 (0.021, 0.055)* 
n=672 
0.000 (-0.011, 0.012) 
n=433 
0.010 (0.001, 0.020)* 
n=496 
1.09 (0.51, 2.34) 
ncases=13 
Quartile 2 0.024 (0.004, 0.044)* 
n=600 
0.007 (-0.011, 0.024) 
n=644 
0.000 (-0.011, 0.011) 
n=448 
0.005 (-0.005, 0.014) 
n=477 
0.95 (0.43, 2.11) 
ncases=11 
Quartile 3 0.006 (-0.013, 0.026) 
n=630 
0.015 (-0.002, 0.032) 
n=693 
0.000 (-0.011, 0.011) 
n=468 
0.001 (-0.009, 0.010) 
n=516 
0.80 (0.35, 1.82) 
ncases=10 










Trend|| -0.013 (-0.020, -0.005)* -0.013 (-0.019, -0.007)* 0.000 (-0.004, 0.005) -0.003 (-0.007, 0.000) 1.02 (0.76, 1.36) 
DASH, Dietary Approaches to Stop Hypertension. UmPI, umbilical artery pulsatility index. UtRI, uterine artery resistance index.  
*P-value<0.05. †Values are regression coefficients (95% confidence interval) and reflect differences in UmPI and UtRI per DASH quartile. Groups are 
compared to women with the highest dietary quality according to the DASH score (quartile 4) as reference. Estimates are from multiple imputed data. ‡Models 
are adjusted for gestational age at the time of intake. §Values are odds ratios (95% confidence interval) that reflect difference in risks of late-pregnancy 
notching per DASH quartile. Groups are compared to women with a healthy dietary pattern (quartile 4) as reference. Estimates are from multiple imputed 
data. || Trends were based on multiple linear regression models with DASH as SDS for UmPI and UtPI, and on multiple logistic regression models with DASH 
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Table S6. Longitudinal associations between DASH score and umbilical artery pulsatility index and uterine artery resistance index*  
DASH, Dietary Approaches to Stop Hypertension. CI, Confidence interval.  
*Values are based on repeated non-linear regression models and reflect the change in umbilical artery pulsatility index and uterine artery resistance index per 
DASH quartile compared to women with the highest dietary quality (quartile 4) as reference. Models are adjusted for gestational age at the time of 





 Difference in umbilical artery pulsatility index 
DASH Intercept P-value
† Slope (95% CI) P-value† 
Quartile 1 1.642 0.39 0.0002 (-0.002, 0.002) 0.86 
Quartile 2 1.690 0.01 -0.002 (-0.004, -0.000) 0.04 
Quartile 3 1.628 0.66 -0.0001 (-0.002, 0.002) 0.96 
Quartile 4 1.615 Reference Reference  Reference 
 Difference in uterine artery resistance index  
DASH Intercept
 P-value† Slope (95% CI) P-value† 
Quartile 1 0.637 0.23 0.001 (-0.0002, 0.002) 0.70 
Quartile 2 0.636 0.21 0.001 (-0.0003, 0.002) 0.64 
Quartile 3 0.651 0.77 0.0001 (-0.001, 0.001) 0.54 
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Table S7. Secondary outcome: associations of DASH score with uterine artery pulsatility index 
(n=3,414). 
UtPI, Uterine artery pulsatility index. DASH, Dietary Approaches to Stop Hypertension. Sd, standard 
deviation. CI, Confidence Interval.  
*Values are mean UtPI values (sd) and reflect the absolute value in uterine artery pulsatility index per 
DASH Quartile. P-values for comparison of absolute values among the four DASH quartiles were 
obtained by ANOVA (mid-pregnancy UtPI, p-value=0.693; late-pregnancy UtPI, p-value 0.387). 
†Values are regression coefficients (95% confidence interval) and reflect differences in UtPI per 
DASH Quartile. Groups are compared to women with the highest dietary quality according to the 
DASH score (Quartile 4) as reference. Estimates are from multiple imputed data. R^2 values for 
confounder models: mid-pregnancy UtPI, R^2=0.02; late-pregnancy UtPI, R^2=0.02.‡Models are 
adjusted for gestational age at intake.§Models are adjusted for maternal age, educational level, parity, 
prepregnancy BMI, smoking habits, alcohol use, folic acid use, total energy intake and gestational age 
at time of the measurements. ||Trends were based on multiple linear regression models with DASH 
dietary score as SDS. R^2 values for confounder models: mid-pregnancy UtPI, R^2=0.02; late-




  Absolute values and differences in UtPI 




DASH    
Quartile 1 Absolute mean value (sd)* 0.895 (0.275) 0.751 (0.199) 
 Basic model†,‡ 0.020 (-0.017, 0.057) 0.022 (-0.004, 0.048) 
 Confounder model†,§ 0.013 (-0.026, 0.053) 
n=342 
0.013 (-0.015, 0.041) 
n=417 
Quartile 2 Absolute mean value (sd)* 0.883 (0.261) 0.736 (0.189) 
 Basic model†,‡ 0.009 (-0.028, 0.045) 0.007 (-0.019, 0.032) 
 Confounder model†,§ 0.010 (-0.027, 0.046) 
n=354 
0.006 (-0.020, 0.033) 
n=408 
Quartile 3 Absolute mean value (sd)* 0.875 (0.252) 0.735 (0.206) 
 Basic model†,‡ 0.000 (-0.35, 0.036) 0.006 (-0.019, 0.031) 
 Confounder model†,§ 0.000 (-0.036, 0.035) 
n=394 
0.004 (-0.021, 0.029) 
n=438 
Quartile 4 Absolute mean value (sd)* 0.875 (0.256) 0.729 (0.187) 
 Basic model†,‡ Reference Reference 




Trendd Basic model‡,|| -0.004 (-0.017) -0.006 (-0.015, 0.003) 
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Table S8. Basic models: associations of maternal DASH score the risks of gestational 
hypertensive disorder (3,414)*. 
DASH, Dietary Approaches to Stop Hypertension. CI, Confidence Interval.  
*Values are odds ratios (95% confidence interval) that reflect difference in risks of gestational 
hypertensive disorders, gestational hypertension and preeclampsia per DASH quartile. Groups are 
compared to women with the highest dietary quality according to the DASH score(quartile 4) as 
reference. Estimates are from multiple imputed data. Models are adjusted for gestational age at the 




Gestational hypertension Preeclampsia 
DASH 
Odds ratio (95% CI) 
ncases=232 
Odds ratio (95% CI) 
ncases=173 
Odds ratio (95% CI) 
ncases=59 
Quartile 1 1.31 (0.91, 1.88) 
ncases=70 
1.22 (0.81, 1.84) 
ncases=51 
1.62 (0.79, 3.30) 
ncases=19 
Quartile 2 0.96 (0.65, 1.42) 
ncases=49 
1.05 (0.68, 1.61) 
ncases=42 
0.62 (0.25, 1.57) 
ncases=7 
Quartile 3 1.00 (0.69, 1.47) 
ncases=54 
0.81 (0.51, 1.27) 
ncases=34 
1.70 (0.84, 3.43) 
ncases=20 
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Table S9. Sensitivity analysis: associations of maternal DASH score with systolic and diastolic blood pressure in early-, mid- and late-pregnancy in 
participants without pre-existent diabetes or gestational diabetes (n=3,378). 








Quartile 1 Absolute mean value (sd)†  117.65 (11.79) 119.43 (12.02) 121.14 (12.01) 
 Basic model‡,§  0.98 (-0.24, 2.20) 1.91* (0.80, 3.02) 1.66* (0.58, 2.73) 
 Confounder model‡,|| -0.53 (-1.77, 0.70) 
n=692 
0.01 (-1.14, 1.15) 
n=809 
-0.26 (-1.38, 0.86) 
n=811 
Quartile 2 Absolute mean value (sd)†   117.17 (12.38) 118.77 (12.23) 120.93 (11.68) 
 Basic model‡,§ 0.48 (-0.76, 1.72) 1.22* (0.09, 2.35) 1.44* (0.35, 2.54) 
 Confounder model‡,|| -0.51 (-1.68, 0.67) 
n=657 
0.06 (-1.02, 1.13) 
n=765 
0.38 (-0.67, 1.43) 
n=774 
Quartile 3 Absolute mean value (sd)†   117.17 (12.27) 117.94 (11.71) 119.64 (10.92) 
 Basic model‡,§ 0.53 (-0.69, 1.75) 0.43 (-0.69, 1.54) 0.16 (-0.92, 1.24) 
 Confounder model‡,|| -0.06 (-1.20, 1.08) 
n=696 
-0.18 (-1.22, 0.87) 
n=799 
-0.34 (-1.37, 0.68) 
n=806 
Quartile 4 Absolute mean value (sd)†   116.63 (10.97) 117.48 (10.89) 119.48 (10.81) 
 Basic model‡,§ Reference Reference Reference  






Trend‡ Basic model‡ -0.33 (-0.76, 0.11) -0.75* (-1.15, -0.35) -0.66* (-1.05, -0.27) 
 Confounder model§ 0.26(-0.19, 0.71) -0.01 (-0.43, 0.41) 0.10 (-0.31, 0.51) 








Quartile 1 Absolute mean value (sd)†   68.80 (9.14) 68.22 (9.74) 69.86 (9.59) 
 Basic model‡,§ 0.65 (-0.29, 1.59) 2.16* (1.28, 3.03) 1.03* (0.16, 1.90) 
 Confounder model‡,|| 0.15 (-0.81, 1.10) 
n=692 
1.34* (0.44, 2.24) 
n=808 
0.04 (-0.84, 0.93) 
n=811 
Quartile 2 Absolute†   68.43 (10.00) 67.56 (9.70) 69.47 (9.25) 
 Basic model‡,§ 0.25 (-0.70, 1.21) 1.49* (0.60, 2.37) 0.63 (-0.25, 1.51) 
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DASH, Dietary Approaches to Stop Hypertension. Sd, standard deviation. SBP, systolic blood pressure. DBP, diastolic blood pressure.  
* P-value<0.05. †Values are mean blood pressure values (sd) and reflect the absolute value in SBP and DBP per DASH Quartile. P-values for comparison of 
absolute values among the four DASH quartiles were obtained by ANOVA (early-pregnancy SBP, p-value=0.433; mid-pregnancy SBP, p-value=0.003; late-
pregnancy SBP, p-value=0.003; early-pregnancy DBP, p-value=0.522; mid-pregnancy DBP, p-value<0.001; late-pregnancy DBP, p-value=0.081). ‡Values 
are regression coefficients (95% confidence interval) and reflect the difference in mmHg blood pressure per DASH Quartile. Groups are compared to women 
with the lowest DASH dietary score (Quartile 4) as reference. Estimates are from multiple imputed data. R^2 values for confounder models: early-pregnancy 
SBP, R^2=0.14; mid-pregnancy SBP, R^2=0.15, late-pregnancy SBP, R^2=0.12; early-pregnancy DBP, R^2=0.14; mid-pregnancy DBP, R^2=0.16; late-
pregnancy, R^2=0.15. §Models are adjusted for gestational age at intake.||Models are adjusted for maternal age, educational level, parity, prepregnancy BMI, 
smoking habits, alcohol use, folic acid use, total energy intake and gestational age at time of the measurements. #Trends were based on multiple linear 
regression models with DASH dietary score as SDS. R^2 values for confounder models: early-pregnancy SBP, R^2=0.14; mid-pregnancy SBP, R^2=0.15, 




n=657 n=765 n=773 
Quartile 3 Absolute mean value (sd)†   68.28 (8.97) 66.77 (8.87) 68.97 (8.73) 
 Basic model‡,§ 0.16 (-0.78, 1.10) 0.71 (-0.17, 1.59) 0.13 (-0.74, 1.00) 
 Confounder model‡,|| -0.25 (-1.13, 0.63) 
n=696 
0.30 (-0.52, 1.12) 
n=799 
-0.26 (-1.07, 0.55) 
n=806 
Quartile 4 Absolute mean value (sd)†   68.10 (8.54) 66.05 (8.50) 68.83 (8.96) 
 Basic model‡,§ Reference Reference Reference 






Trend# Basic model‡  -0.23 (-0.57, 0.11) -0.79* (-1.10, -0.47) -0.43* (-0.74, -0.12) 
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Table S10. Sensitivity analysis: associations of DASH score with placental vascular function in participants without pre-existent or gestational 
diabetes (n=3,378). 
UmPI, umbilical artery pulsatility index. UtRI, umbilical artery resistance index. DASH, Dietary Approaches to Stop Hypertension. Sd, standard deviation.    
* P-value<0.05. †Values are mean values (sd) and reflect the absolute value in UmPI and UtRI per DASH Quartile. P-values for comparison of absolute values 
among the four DASH quartiles were obtained by ANOVA (mid-pregnancy UmPI, p-value=0.016; late-pregnancy UmPI, p-value<0.001; mid-pregnancy 
UtRI, p-value=1.000; late-pregnancy UtRI, p-value=0.108).‡Values for UmPI and UtRI are regression coefficients (95% confidence interval) and reflect the 
difference in UmPI and UtRI per DASH Quartile. Values for bilateral notching are odds ratios (95% confidence interval) that reflect difference in risks of 
bilateral notching per DASH Quartile. Groups are compared to women with the lowest DASH dietary score (Quartile 4) as reference. Estimates are from 
multiple imputed data. R^2 values for confounder models: mid-pregnancy UmPI, R^2=0.07; late-pregnancy UmPI, R^2=0.04; mid-pregnancy UtRI, 
 
 Absolute values and differences in UmPI*,† Absolute values and differences in UtRI*,† Bilateral 
notching‡,† 









ncases=48 DASH  
Quartile 1 Absolute mean value (sd)†   1.201 (0.181) 0.999 (0.177) 0.536 (0.091) 0.490 (0.076) n.a. 
 Basic model‡,§  0.026* (0.006, 0.046) 0.036* (0.019, 0.053) 0.000 (-0.11, 0.012) 0.010* (0.001, 0.020) 1.05 (0.52, 2.37) 
 Confounder model‡,|| 
 
0.011 (-0.010, 0.032) 
n=489 





0.009 (-0.001, 0.019) 
n=589 
1.12 (0.51, 2.45) 
ncases=13 
Quartile 2 Absolute mean value (sd)†   1.199 (0.184) 0.969 (0.160) 0.535 (0.090) 0.484 (0.076) n.a. 
 Basic model‡,§ 0.024* (0.004, 0.044) 0.007 (-.010, 0.024) 0.000 (-0.011, 0.012) 0.005 (-0.005, 0.014) 0.96 (0.43, 2.13) 
 Confounder model‡,|| 
 
0.019 (-0.001, 0.039) 
n=473 
0.002 (-0.016, 0.019) 
n=637 
0.000 (-0.011, 0.011) 
n=446 
0.005 (-0.004, 0.014) 
n=596 
0.95 (0.43, 2.11) 
ncases=11 
Quartile 3 Absolute mean value (sd)†   1.180 (0.186) 0.978 (0.163) 0.535 (0.089) 0.480 (0.081) n.a. 
 Basic model‡,§  0.005 (-0.014, 0.025) 0.015 (-0.002, 0.032) 0.000 (-0.011, 0.012) 0.000 (-0.009, 0.010) 0.81 (0.36, 1.84) 
 Confounder model‡,|| 
 
0.008 (-0.011, 0.27) 
n=511 
0.015 (-0.002, 0.032) 
n=686 
0.000 (-0.012, 0.011) 
n=463 
0.000 (-0.010, 0.009) 
n=623 
0.83 (0.37, 1.89) 
ncases=10 
Quartile 4 Absolute mean value (sd)†   1.174 (0.182) 0.962 (0.162) 0.535 (0.088) 0.479 (0.077) n.a. 
 Basic model‡,§  Reference Reference Reference Reference Reference 
















0.001 (-0.004, 0.005) -0.003 (-0.007, 
0.000) 
1.01 (0.76, 1.35) 




0.002 (-0.003, 0.006) -0.003 (-0.006, 
0.001) 




 http://ahajournals.org by on February 10, 2021
 
 
R^2=0.02; late-pregnancy UtRI, R^2=0.03; bilateral notching R^2=0.01.§Models are adjusted for gestational age at intake. || Models for UmPI and UtRI are 
adjusted for maternal age, educational level, parity, prepregnancy BMI, smoking habits, alcohol use, folic acid use, total energy intake and gestational age at 
time of the measurements. Models for bilateral notching are adjusted for parity, prepregnancy BMI, folic acid use and gestational age at time of measurement.   
#Trends were based on multiple linear regression models with DASH dietary score as SDS for UmPI and UtRI; and on multiple logistic regression models 
with DASH dietary score as SDS for bilateral notching. R^2 values for confounder models: mid-pregnancy UmPI, R^2=0.07; late-pregnancy UmPI, 
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Table S11. Sensitivity analysis: associations of maternal DASH score the risks of gestational hypertensive disorder in participants without pre-
existent or gestational diabetes (n=3,378)*.  
DASH, Dietary Approaches to Stop Hypertension. CI, Confidence Interval. GHD, Gestational hypertensive disorders. GH, Gestational Hypertension. PE, 
Preeclampsia. 
*Values are odds ratios (95% confidence interval) that reflect difference in risks of gestational hypertensive disorders, gestational hypertension and 
preeclampsia per DASH Quartile. Groups are compared to women with the lowest DASH dietary score (Quartile 1) as reference. Estimates are from multiple 
imputed data. R^2 values for confounder models: GHD, R^2=0.09; GH, R^2=0.09; PE, R^2=0.08. †Models are adjusted for gestational age at intake. ‡ Models 
are adjusted for parity, prepregnancy BMI, folic acid use and gestational age at time of intake.   §Trends were based on multiple logistic regression models 




 Gestational hypertensive 
disorders 
Gestational hypertension Preeclampsia 
DASH 
 Odds ratio (95% CI) 
ncases=224
 
Odds ratio (95% CI) 
ncases=166 
Odds ratio (95% CI) 
ncases=224 
Quartile 1 Basic model† 1.31 (0.91, 1.88) 1.21 (0.80, 1.84) 1.63 (0.80, 3.33) 
 Confounder model‡ 1.15 (0.79, 1.69) 
ncases=68 
1.04 (0.67, 1.61) 
ncases=49 
1.50 (0.72, 3.16) 
ncases=19 
Quartile 2 Basic model† 0.89 (0.60, 1.34) 1.00 (0.64, 1.55) 0.54 (0.20, 1.41) 
 Confounder model‡ 0.79 (0.53, 1.20) 
ncases=45 
0.87 (0.55, 1.37) 
ncases=39 
0.50 (0.19, 1.33) 
ncases=6 
Quartile 3 Basic model† 1.01 (0.69, 1.48) 0.81 (0.51, 1.28) 1.71 (0.84, 3.45) 
 Confounder model‡ 0.96 (0.65, 1.43) 
ncases=53 
0.74 (0.46, 1.18) 
ncases=33 
1.78 (0.87, 3.62) 
ncases=20 
Quartile 4 Basic model† Reference Reference Reference 






Trend§ Basic model† 0.91 (0.79, 1.04) 0.91 (0.78, 1.06) 0.90 (0.69, 1.16) 
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Table S12. Sensitivity analysis: associations of maternal DASH score with systolic and diastolic blood pressure in early-, mid- and late-pregnancy in 
participants without heart condition or hypercholesterolemia (n=3,356)*. 








Quartile 1 Absolute mean value (sd)†  117.77 (11.84) 119.56 (12.05) 121.25 (12.17) 
 Basic model‡,§  1.09 (-0.14, 2.33) 2.07* (0.95, 3.18) 1.73* (0.64, 2.82) 
 Confounder model‡,|| -0.44 (-1.68, 0.81) 
n=688 
0.12 (-1.03, 1.26) 
n=809 
-0.20 (-1.33, 0.93) 
n=808 
Quartile 2 Absolute mean value (sd)†   117.44 (12.61) 118.82 (12.21) 121.04 (11.75) 
 Basic model‡,§ 0.75 (-0.50, 2.00) 1.30* (0.17, 2.43) 1.51* (0.41, 2.61) 
 Confounder model‡,|| -0.35 (-1.54, 0.83) 
n=655 
0.06 (-1.02, 1.14) 
n=762 
0.39 (-0.67, 1.45) 
n=771 
Quartile 3 Absolute mean value (sd)†   117.26 (12.29) 118.02 (11.68) 119.68 (10.95) 
 Basic model‡,§ 0.61 (-0.62, 1.84) 0.52 (-0.60, 1.64) 0.15 (-0.94, 1.25) 
 Confounder model‡,|| -0.01 (-1.16, 1.15) 
n=696 
-0.11 (-1.17, 0.94) 
n=795 
-0.36 (1.40, 0.68) 
n=802 
Quartile 4 Absolute mean value (sd)†   116.63 (11.02) 117.45 (10.93) 119.51 (10.87) 
 Basic model‡,§ Reference Reference Reference 






Trend# Basic model‡ -0.38 (-0.82, 0.06) -0.79* (-1.19, -0.39) -0.67*  (-1.07, -0.28) 
 Confounder model§ 0.23 (-0.23, 0.68) -0.03 (-0.45, 0.39) 0.10 (-0.31, 0.51) 








Quartile 1 Absolute mean value (sd)†  68.70 (9.01) 68.27 (9.80) 69.88 (9.62) 
 Basic model‡,§  0.56 (-0.39, 1.50) 2.20* (1.32, 3.09) 1.03* (0.15, 1.90) 
 Confounder model‡,|| 0.02 (-0.94, 0.97) 
n=688 
1.28* (0.37, 2.18) 
n=808 
0.01 (-0.88, 0.90) 
n=808 
Quartile 2 Absolute mean value (sd)†   68.61 (10.08) 67.67 (9.76) 69.53 (9.26) 
 Basic model‡,§ 0.45 (-0.51, 1.41) 1.60* (0.70, 2.50) 0.67 (-0.21, 1.56) 
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DASH, Dietary Approaches to Stop Hypertension. Sd, standard deviation. SBP, systolic blood pressure. DBP, diastolic blood pressure.  
* P-value<0.05. †Values are mean blood pressure values (sd) and reflect the absolute value in SBP and DBP per DASH Quartile. P-values for comparison of 
absolute values among the four DASH quartiles were obtained by ANOVA (early-pregnancy SBP, p-value=0.324; mid-pregnancy SBP, p-value=0.001; late-
pregnancy SBP, p-value=0.002; early-pregnancy DBP, p-value=0.324; mid-pregnancy DBP, p-value=0.001; late-pregnancy DBP, p-value=0.002). ‡Values 
are regression coefficients (95% confidence interval) and reflect the difference in mmHg blood pressure per DASH Quartile. Groups are compared to women 
with the lowest DASH dietary score (Quartile 4) as reference. Estimates are from multiple imputed data. R^2 values for confounder models: early-
pregnancy SBP, R^2=0.14; mid-pregnancy SBP, R^2=0.15, late-pregnancy SBP, R^2=0.12; early-pregnancy DBP, R^2=0.14; mid-pregnancy DBP, 
R^2=0.16; late-pregnancy, R^2=0.15.§Models are adjusted for gestational age at intake.||Models are adjusted for maternal age, educational level, parity, 
prepregnancy BMI, smoking habits, alcohol use, folic acid use, total energy intake and gestational age at time of the measurements. #Trends were based on 
multiple linear regression models with DASH dietary score as SDS. R^2 values for confounder models: early-pregnancy SBP, R^2=0.14; mid-pregnancy 
SBP, R^2=0.15, late-pregnancy SBP, R^2=0.12; early-pregnancy DBP, R^2=0.14; mid-pregnancy DBP, R^2=0.16; late-pregnancy, R^2=0.15. 
 
 
n=655 n=762 n=770 
Quartile 3 Absolute mean value (sd)†   68.32 (9.03) 66.80 (8.90) 69.03 (8.75) 
 Basic model‡,§ 0.20 (-0.74, 1.15) 0.73 (-0.16, 1.62) 1.18 (-0.70, 1.05) 
 Confounder model‡,|| -0.23 (-1.11, 0.66) 
n=696 
0.29 (-0.54, 1.11) 
n=795 
-0.22 (-1.03, 0.59) 
n=802 
Quartile 4 Absolute mean value (sd)†   68.10 (8.57) 66.06 (8.55) 68.85 (9.01) 
 Basic model‡,§ Reference Reference Reference  






Trend# Basic model‡ -0.21 (-0.54, 0.13) -0.80* (-1.11, -0.48) -0.43* (-0.74, -0.12) 
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Table S13. Sensitivity analysis: associations of DASH score with placental vascular function in participants heart condition or hypercholesterolemia 
(n=3,356). 
UmPI, umbilical artery pulsatility index. UtRI, umbilical artery resistance index. DASH, Dietary Approaches to Stop Hypertension. Sd, standard deviation.   
* P-value<0.05. †Values are mean values (sd) and reflect the absolute value in UmPI and UtRI per DASH Quartile. P-values for comparison of absolute values 
among the four DASH quartiles were obtained by ANOVA (mid-pregnancy UmPI, p-value=0.019; late-pregnancy UmPI, p-value<0.001; mid-pregnancy 
UtRI, p-value=0.998; late-pregnancy UtRI, p-value=0.101). ‡Values for UmPI and UtRI are regression coefficients (95% confidence interval) and reflect the 
difference in UmPI and UtRI per DASH Quartile. Values for bilateral notching are odds ratios (95% confidence interval) that reflect difference in risks of 
bilateral notching per DASH Quartile. Groups are compared to women with the lowest DASH dietary score (Quartile 4) as reference. Estimates are from 
 
 Absolute values and differences in UmPI*,† Absolute values and differences in UtRI*,† Bilateral 
notching‡,† 









ncases=47 DASH  
Quartile 1 Absolute mean value (sd)†   1.201 (0.182) 1.000 (0.178) 0.535 (0.091) 0.490 (0.076) n.a. 
 Basic model‡,§  0.026* (0.006, 0.047) 0.037* (0.020, 0.054) 0.001 (-0.011, 0.012) 0.010* (0.001, 0.020) 1.17 (0.54, 2.56) 









0.010 (0.000, 0.020) 
n=487 
1.2 (0.454, 2.67) 
ncases=13 
Quartile 2 Absolute mean value (sd)†   1.198 (0.184) 0.970 (0.160) 0.535 (0.089) 0.484 (0.076) n.a. 
 Basic model‡,§ 0.024* (0.004, 0.044) 0.006 (-0.011, 0.024) 0.001 (-0.011, 0.012) 0.005 (-0.005, 0.014) 1.01 (0.45, 2.28) 
 Confounder model‡,|| 
 




0.001 (-0.011, 0.012) 
n=440 
0.006 (-0.004, 0.015) 
n=471 
0.88 (0.39, 2.03) 
ncases=11 
Quartile 3 Absolute mean value (sd)†   1.180 (0.186) 0.975 (0.163) 0.534 (0.089) 0.480 (0.081) n.a. 
 Basic model‡,§  0.006 (-0.014, 0.026) 0.012 (-0.005, 0.029) 0.000 (-0.011, 0.011) 0.000 (-0.009, 0.010) 0.86 (0.37, 1.98) 
 Confounder model‡,|| 
 







0.000 (-0.009, 0.009) 
n=508 
0.87 (0.38, 2.01) 
ncases=10 
Quartile 4 Absolute mean value (sd)†   1.174 (0.182) 0.963 (0.162) 0.535 (0.088) 0.479 (0.077) n.a. 
 Basic model‡,§  Reference Reference Reference Reference Reference 
















0.000 (-0.004, 0.004) -0.003 (-0.007, 
0.000) 
0.97 (0.74, 1.33) 
 Confounder model§ -0.007 (-0.014, 
0.001) 
-0.008 * (-0.015, -
0.001) 
0.001 (-0.003, 0.006) -0.003 (-0.007, 
0.001) 
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multiple imputed data. R-squared values for confounder models: mid-pregnancy UmPI, R^2=0.07; late-pregnancy UmPI, R^2=0.04; mid-pregnancy UtRI, 
R^2=0.02; late-pregnancy UtRI, R^2=0.03; bilateral notching R^2=0.01). §Models are adjusted for gestational age at intake.|| Models for UmPI and UtRI are 
adjusted for maternal age, educational level, parity, prepregnancy BMI, smoking habits, alcohol use, folic acid use, total energy intake and gestational age at 
time of the measurements. Models for bilateral notching are adjusted for parity, prepregnancy BMI, folic acid use and gestational age at time of measurement.  
#Trends were based on multiple linear regression models with DASH dietary score as SDS for UmPI and UtRI; and on multiple logistic regression models 
with DASH dietary score as SDS for bilateral notching. R-squared values for confounder models: mid-pregnancy UmPI, R^2=0.07; late-pregnancy UmPI, 
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Table S14. Sensitivity analysis: associations of maternal DASH score the risks of gestational hypertensive disorder in participants without heart 
condition or hypercholesterolemia (n=3,356)*.  
DASH, Dietary Approaches to Stop Hypertension. GHD, Gestational hypertensive disorders. GH, Gestational Hypertension. PE, Preeclampsia. 
*Values are odds ratios (95% confidence interval) that reflect difference in risks of gestational hypertensive disorders, gestational hypertension and 
preeclampsia per DASH Quartile. Groups are compared to women with the lowest DASH dietary score (Quartile 1) as reference. Estimates are from multiple 
imputed data. R^2 values for confounder models: GHD, R^2=0.09; GH, R^2=0.09; PE, R^2=0.09). †Models are adjusted for gestational age at intake. ‡ 
Models are adjusted for parity, prepregnancy BMI, folic acid use and gestational age at time of intake.   §Trends were based on multiple logistic regression 
models with DASH dietary score as SDS. R^2 values for confounder models: GHD, R^2=0.09; GH, R^2=0.09; PE, R^2=0.07).
 
 Gestational hypertensive 
disorders 
Gestational hypertension Preeclampsia 
DASH 
 Odds ratio (95% CI) 
ncases=227
 
Odds ratio (95% CI) 
ncases=167 
Odds ratio (95% CI) 
ncases=59 
Quartile 1 Basic model† 1.32 (0.92, 1.90) 1.23 (0.81, 1.86) 1.63 (0.80, 3.32) 
 Confounder model‡ 1.17 (0.80, 1.71) 
ncases=69 
1.06 (0.69, 1.64) 
ncases=50 
1.49 (0.71, 3.12) 
ncases=19 
Quartile 2 Basic model† 0.95 (0.64, 1.41) 1.04 (0.68, 1.61) 0.62 (0.25, 1.57) 
 Confounder model‡ 0.83 (0.55, 1.25) 
ncases=48 
0.90 (0.58, 1.41) 
ncases=41 
0.57 (0.22, 1.44) 
ncases=7 
Quartile 3 Basic model† 0.98 (0.67, 1.45) 0.78 (0.49, 1.24) 1.70 (0.84, 3.44) 
 Confounder model‡ 0.93 (0.63, 1.38) 
ncases=52 
0.70 (0.44, 1.13) 
ncases=32 
1.74 (0.85, 3.55) 
ncases=20 
Quartile 4 Basic model† Reference Reference Reference 






Trend§ Basic model† 0.89 (0.78, 1.02) 0.89 (0.77, 1.04) 0.90 (0.69, 1.15) 
 Confounder model‡ 0.94 (0.82, 1.09) 0.94 (0.80, 1.11) 0.93 (0.71, 1.22) 
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Table S15. Sensitivity analysis: associations of maternal DASH score with systolic and diastolic blood pressure in early-, mid- and late-pregnancy in 
participants enrolled in the first trimester of pregnancy (n=1,888). 








Quartile 1 Absolute mean value (sd)†  118.03 (11.97) 120.14 (11.80) 120.96 (12.16) 
 Basic model‡,§  1.03 (-0.48, 2.55) 2.02* (0.52, 3.51)  0.73 (-0.74, 2.19) 
 Confounder model‡,|| -0.10 (-1.64, 1.43) 
n=464 
0.81 (-0.71, 2.32) 
n=462 
-0.52 (-2.02, 0.97) 
n=457 
Quartile 2 Absolute mean value (sd)†   117.66 (12.59) 119.47 (12.10) 120.71 (11.95) 
 Basic model‡,§ 0.67 (-0.86, 2.19) 1.35 (-0.16, 2.85) 0.47 (-1.00, 1.95) 
 Confounder model‡,|| -0.12 (-1.56, 1.32) 
n=450 
0.48 (-0.95, 1.90) 
n=447 
-0.28 (-1.68, 1.13) 
n=445 
Quartile 3 Absolute mean value (sd)†   117.67 (12.10) 118.89 (12.12) 119.82 (11.06) 
 Basic model‡,§ 0.70 (-0.81, 2.21) 0.75 (-0.74, 2.25) -0.40 (-1.86, 1.06) 
 Confounder model‡,|| -0.07 (-1.45, 1.39) 
n=462 
0.01 (-1.39, 1.42) 
n=457 
-1.06 (-2.44, 0.32) 
n=456 
Quartile 4 Absolute mean value (sd)†   116.95 (11.03) 118.15 (10.83) 120.21 (10.56) 
 Basic model‡,§ Reference Reference Reference 






Trend# Basic model‡ -0.36 (-0.90, 0.18) -0.78* (-1.32, -0.25) -0.35 (-0.87, 0.18) 
 Confounder model§ 0.04 (-0.52, 0.60) -0.35 (-0.90, 0.21) 0.11 (-0.44, 0.65) 








Quartile 1 Absolute mean value (sd)†  69.43 (9.31) 68.60 (9.75) 69.89 (9.53) 
 Basic model‡,§  1.03 (-0.15, 2.21) 2.36* (1.17, 3.54) 0.44 (-0.73, 1.60) 
 Confounder model‡,|| 0.80 (-0.38, 1.97) 
n=464 
1.87* (0.68, 3.07) 
n=461 
-0.20 (-1.35, 0.95) 
=457 
Quartile 2 Absolute mean value (sd)†   69.15 (10.06) 68.06 (9.90) 69.59 (9.27) 
 Basic model‡,§ 0.76 (-0.43, 1.94) 1.81* (0.62, 3.01) 0.14 (-1.04, 1.31) 
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DASH, Dietary Approaches to Stop Hypertension. Sd, standard deviation. SBP, systolic blood pressure. DBP, diastolic blood pressure.  
* P-value<0.05. †Values are mean blood pressure values (sd) and reflect the absolute value in SBP and DBP per DASH Quartile. P-values for comparison of 
absolute values among the four DASH quartiles were obtained by ANOVA (early-pregnancy SBP, p-value=0.553; mid-pregnancy SBP, p-value=0.059; late-
pregnancy SBP, p-value=0.435; early-pregnancy DBP, p-value=0.359; mid-pregnancy DBP, p-value=0.001; late-pregnancy DBP, p-value=0.716). ‡Values 
are regression coefficients (95% confidence interval) and reflect the difference in mmHg blood pressure per DASH Quartile. Groups are compared to women 
with the lowest DASH dietary score (Quartile 4) as reference. Estimates are from multiple imputed data. R^2 values for confounder models: early-
pregnancy SBP, R^2=0.14; mid-pregnancy SBP, R^2=0.14, late-pregnancy SBP, R^2=0.13; early-pregnancy DBP, R^2=0.16; mid-pregnancy DBP, 
R^2=0.16; late-pregnancy, R^2=0.18. §Models are adjusted for gestational age at intake.||Models are adjusted for maternal age, educational level, parity, 
prepregnancy BMI, smoking habits, alcohol use, folic acid use, total energy intake and gestational age at time of the measurements. #Trends were based on 
multiple linear regression models with DASH dietary score as SDS. R^2 values for confounder models: early-pregnancy SBP, R^2=0.14; mid-pregnancy 
SBP, R^2=0.14, late-pregnancy SBP, R^2=0.13; early-pregnancy DBP, R^2=0.16; mid-pregnancy DBP, R^2=0.16; late-pregnancy, R^2=0.18.  
n=450 n=447 n=444 
Quartile 3 Absolute mean value (sd)†   68.88 (9.23) 67.15 (9.17) 69.20 (8.98) 
 Basic model‡,§ 0.48 (-0.69, 1.66) 0.88 (-0.31, 2.07) -0.24 (-1.41, 0.93) 
 Confounder model‡,|| -0.08 (-1.17, 1.01) 
n=462 
0.30 (-0.81, 1.40) 
n=457 
-0.86 (-1.92, 0.21) 
n=456 
Quartile 4 Absolute mean value (sd)†   68.40 (8.42) 66.29 (8.39) 69.43 (8.74) 
 Basic model‡,§ Reference Reference Reference 






Trend# Basic model‡ -0.39 (-0.81, 0.03) -0.80* (-1.23, -0.38) -0.24 (-0.66, 0.18) 
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Table S16. Sensitivity analysis: associations of DASH score with placental vascular function in participants enrolled in the first trimester of 
pregnancy (n=1,888). 
UmPI, umbilical artery pulsatility index. UtRI, umbilical artery resistance index. DASH, Dietary Approaches to Stop Hypertension. Sd, standard deviation.  
* P-value<0.05. †Values are mean values (sd) and reflect the absolute value in UmPI and UtRI per DASH Quartile. P-values for comparison of absolute values 
among the four DASH quartiles were obtained by ANOVA (mid-pregnancy UmPI, p-value=0.308; late-pregnancy UmPI, p-value=0.002; mid-pregnancy 
UtRI, p-value=0.927; late-pregnancy UtRI, p-value=0.123). ‡Values for UmPI and UtRI are regression coefficients (95% confidence interval) and reflect the 
difference in UmPI and UtRI per DASH Quartile. Values for bilateral notching are odds ratios (95% confidence interval) that reflect difference in risks of 
bilateral notching per DASH Quartile. Groups are compared to women with the lowest DASH dietary score (Quartile 4) as reference. Estimates are from 
  Absolute values and differences in UmPI
*,† Absolute values and differences in UtRI*,† Bilateral notching† 









ncases=30 DASH  
Quartile 1 Absolute mean value 
(sd)†   
1.209 (0.180) 1.002 (0.173) 0.536 (0.089) 0.490 (0.075) n.a. 
 Basic model‡,§  0.022 (-0.004, 0.048) 0.035§ (0.013, 0.057) 0.000 (-0.014, 0.015) 0.012 (0.000, 0.024) 0.50 (0.17, 1.47) 
 Confounder model‡,|| 
 
0.001 (-0.026, 0.028) 
n=361 
0.017 (-0.006, 0.041) 
n=397 
0.002 (-0.014, 0.017) 
n=271 
0.013 (0.000, 0.026) 
n=297 
0.53 (0.18, 1.56) 
ncases=5 
Quartile 2 Absolute mean value 
(sd)†   
1.196 (0.188) 0.960 (0.156) 0.536 (0.092) 0.486 (0.077) n.a. 
 Basic model‡,§ 0.010 (-0.016, 0.036) -0.007 (-0.029, 0.016) 0.000 (-0.014, 0.015) 0.008 (-0.005, 0.020) 0.55 (0.19, 1.60) 
 Confounder model‡,|| 
 
0.005 (-0.020, 0.031) 
n=371 
-0.015 (-0.037, 0.008) 
n=382 
0.002 (-0.012, 0.017) 
n=282 
0.008 (-0.004, 0.021) 
n=276 
0.54 (0.18, 1.57) 
ncases=5 
Quartile 3 Absolute mean value 
(sd)†   
1.190 (0.176) 0.973 (0.159) 0.532 (0.089) 0.478 (0.081) n.a. 
 Basic model‡,§  0.005 (-0.021, 0.030) 0.007 (-0.015, 0.029) -0.004 (-0.018, 0.010) -0.001 (-0.013, 0.011) 0.86 (0.35, 2.10) 
 Confounder model‡,|| 
 
0.008 (-0.017, 0.033) 
n=383 
0.005 (-0.017, 0.027) 
n=412 
-0.002 (-0.016, 0.013) 
n=291 
-0.000 (-0.012, 0.011) 
n=321 
0.85 (0.35, 2.08) 
ncases=9 
Quartile 4 Absolute mean value 
(sd)†   
1.185 (0.183) 0.965 (0.164) 0.536 (0.090) 0.478 (0.074) n.a.  
 Basic model‡,§  Reference Reference Reference Reference Reference 












Trend# Basic model‡  -0.008 (-0.017, 
0.002) 
-0.009 § (-0.018, -
0.001) 
0.000 (-0.005, 0.005) 0.000 (-0.008, 0.000) 1.45 (0.99, 2.14) 
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multiple imputed data. R^2 values for confounder models: mid-pregnancy UmPI, R^2=0.07; late-pregnancy UmPI, R^2=0.05; mid-pregnancy UtRI, 
R^2=0.02; late-pregnancy UtRI, R^2=0.04; bilateral notching R^2=0.02. §Models are adjusted for gestational age at intake. ||Models for UmPI and UtRI are 
adjusted for maternal age, educational level, parity, prepregnancy BMI, smoking habits, alcohol use, folic acid use, total energy intake and gestational age at 
time of the measurements. Models for bilateral notching are adjusted for parity, prepregnancy BMI, folic acid use and gestational age at time of measurement.  
#Trends were based on multiple linear regression models with DASH dietary score as SDS for UmPI and UtRI; and on multiple logistic regression models 
with DASH dietary score as SDS for bilateral notching. R^2 values for confounder models: mid-pregnancy UmPI, R^2=0.07; late-pregnancy UmPI, 
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Table S17. Sensitivity analysis: associations of maternal DASH score the risks of gestational hypertensive disorder in participants enrolled in the first 
trimester of pregnancy (n=1,888)*. 
 
DASH, Dietary Approaches to Stop Hypertension. CI, Confidence Interval. GHD, Gestational hypertensive disorders. GH, Gestational Hypertension. PE, 
Preeclampsia. 
*Values are odds ratios (95% confidence interval) that reflect difference in risks of gestational hypertensive disorders, gestational hypertension and 
preeclampsia per DASH Quartile. Groups are compared to women with the lowest DASH dietary score (Quartile 1) as reference. Estimates are from multiple 
imputed data. R^2 values for confounder models: GHD, R^2=0.11; GH, R^2=0.12; PE, R^2=0.09. †Models are adjusted for gestational age at intake. 
‡Models are adjusted for parity, prepregnancy BMI, folic acid use, and gestational age at time of intake.  §Trends were based on multiple logistic regression 
models with DASH dietary score as SDS. R^2 values for confounder models: GHD, R^2=0.10; GH, R^2=0.11; PE, R^2=0.05. 
 
 Gestational hypertensive 
disorders 
Gestational hypertension Preeclampsia 
DASH 
 Odds ratio (95% CI) 
ncases=124
 
Odds ratio (95% CI) 
ncases=96 
Odds ratio (95% CI) 
ncases=28 
Quartile 1 Basic model† 1.22 (0.75, 1.99) 1.03 (0.60, 1.78) 2.29 (0.79, 6.66) 
 Confounder model‡ 1.10 (0.66, 1.82) 
ncases=39 
0.91 (0.51, 1.61) 
ncases=28 
2.04 (0.68, 6.11) 
ncases=11 
Quartile 2 Basic model† 0.75 (0.44, 1.30) 0.85 (0.48, 1.50) 0.21 (0.02, 1.80) 
 Confounder model‡ 0.65 (0.37, 1.14) 
ncases=24 
0.72 (0.40, 1.30) 
ncases=23 
0.19 (0.02, 1.65) 
ncases=1 
Quartile 3 Basic model† 0.88 (0.52, 1.48) 0.63 (0.34, 1.16) 2.28 (0.78, 6.61) 
 Confounder model‡ 0.76 (0.44, 1.29) 
ncases=28 
0.51 (0.27, 0.98)* 
ncases=17 
2.16 (0.74, 6.30) 
ncases=11 
Quartile 4 Basic model† Reference Reference Reference 






Trend§ Basic model† 0.93 (0.77, 1.12) 0.96 (0.78, 1.18) 0.82 (0.57, 1.20) 
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Table S18. Associations of maternal DASH score with the risks of gestational hypertensive disorder with adjustment for propensity score (1,780) *. 
 




Odds ratio (95% CI) 
ncases=232
 
Odds ratio (95% CI) 
ncases=173 
Odds ratio (95% CI) 
ncases=59 
Quartile 1 1.18 (0.49, 2.83) 
ncases=13 
1.15 (0.75, 1.75) 
ncases=70 
0.96 (0.59, 1.57) 
ncases=51 
1.89 (0.84, 4.23) 
ncases=19 








Propensity score 1.46 (0.25, 8.49) 0.61 (0.27, 1.36) 0.42 (0.17, 1.05) 1.85 (0.39, 8.68) 
DASH, Dietary Approaches to Stop Hypertension. CI, Confidence Interval. GHD, Gestational hypertensive disorders. GH, Gestational Hypertension. PE, 
Preeclampsia. 
* Values are odds ratios (95% confidence interval) that reflect difference in risks of bilateral uterine artery notching, gestational hypertensive disorders, 
gestational hypertension and preeclampsia per DASH quartile. DASH score quartile 1 is compared to DASH score quartile 4 as a reference category. 
Estimates are from multiple imputed data. Models are adjusted for propensity scores that were calculated using a logistic regression model to predict the 
likelihood of having a DASH score in quartile 1 rather than quartile 4. R^2 values for confounder models: bilateral notching R^2=0.001, GHD, R^2=0.01; 






 http://ahajournals.org by on February 10, 2021
 
 





Pregnant women of Dutch ethnicity 
enrolled during pregnancy  
 
n= 3,558 
Pregnant women with data on dietary intake  
 
n= 3,494 
Pregnant women without pre-existent 
hypertension with data on blood pressure, 
placental hemodynamics or gestational 
hypertensive disorders 
n= 3,414 
Population for analysis: Mothers with 
singleton live births with information 
available on dietary intake, blood pressure, 
placental hemodynamics and hypertensive 
disorders 
 
Data on blood pressure, n= 3,411 
Data on placental hemodynamics, n= 3,119 
Data on gestational hypertensive disorders, 
n= 3,333 
 
n= 538 excluded: 
No data on dietary intake for DASH score 
calculation 
 
n= 64 excluded: 
No data on blood pressure, placental hemodynamics 
or gestational hypertensive disorders, n= 1 
Pre-existent hypertension, n= 63 
n=80 excluded: 
Loss to follow up, n=3 
Multiple pregnancy, n=53 
Intrauterine fetal death, n=16 
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Pregnant women of Dutch ethnicity without 
data on dietary intake for DASH score 
calculation 
n= 531 
Pregnant women without pre-existent 
hypertension with data on blood pressure, 




n= 7 excluded: 
No data on blood pressure, placental hemodynamics 
or gestational hypertensive disorders, n= 0 
Pre-existent hypertension, n= 7 
n=19 excluded: 
Loss to follow up, n=0 
Multiple pregnancy, n=4 
Intrauterine fetal death, n=6 
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